<DOC>
	<DOCNO>NCT02110459</DOCNO>
	<brief_summary>To investigate pharmacokinetics ( PK ) POL7080 subject renal function impairment single intravenous ( IV ) infusion POL7080</brief_summary>
	<brief_title>Pharmacokinetics Safety POL7080 Patients With Renal Impairment</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>1 . Subjects sign informed consent . 2 . Male subject ≥18 ≤79 year age ; female subject ≥18 ≤79 year age nonchildbearing potential 3 . Weight within BMI range 19.035.0 kg/m2 . 4 . CLCr accord Cockcroft Gault equation : 5080 mL/min ( mild renal impairment ) 30 &lt; 50 mL/min ( moderate renal impairment ) &lt; 30 mL/min ( severe renal impairment ) subject receive dialysis ≥3 month dose ( ESRD ) &gt; 80 mL/min ( normal renal function ) 1 . Unwilling unable give inform consent . 2 . As result medical screening process , study physician considers subject unfit study . 3 . Demonstrating excess xanthine consumption ( 5 cup coffee equivalent per day ) . 4 . Subjects smoke 10 cigarette day . 5 . Subjects consume 28 unit ( male ) 21 unit ( female ) alcohol per week . 6 . Any history hypersensitivity IMP . 7 . For subject renal impairment : No clinically significant change disease status within least 1 month prior study entry , determine investigator . 8 . The subject donate unit blood ( 450 mL ) within 3 month dose , intend donate month last scheduled visit . 9 . Participation another clinical study investigational drug device within last month . 10 . Subjects clinically significant telemetric ECG abnormality Day 1 11 . Significant allergy require intranasal systemic corticosteroid time year history anaphylactic reaction . 12 . Positive test human immunodeficiency virus ( HIV ) antibody . 13 . Acute Hepatitis B C infection . 14 . The subject test positive drug abuse screen . 15 . Subjects receive prescribed systemic topical medication within 4 week prior dose ( exclude drug renally impaired subject currently take treatment renal concomitant disease ) . 16 . Immunocompromised patient ( patient solid organ bone marrow transplant ; patient receive immunosuppressive treatment ) . 17 . Subjects know suspected Pseudomonas infection colonization ( e.g . patient cystic fibrosis ) . 18 . Subjects significant liver function abnormality 19 . Subjects acute myocardial infection unstable angina pectoris</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>POL7080</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>